Trends Microbiol
Manufacturer: Independently published
Eight major RCTs of GLP-1RAs have investigated the cardiovascular outcomes, including the ELIXA trial of lixisenatide (250), the EXSCEL trial of exenatide ER (251), the LEARDER trial of liraglutide (252), the SUSTAIN-6 trial of subcutaneous semaglutide (253), the HARMONY trial of albiglutide (228), the REWIND trial of dulaglutide (254), the PIONEER trial of oral semaglutide (255), and the SELECT trial of subcutaneous semaglutide (199)
Glutamate cysteine ligase (GCL) catalyzes ligation of cysteine and glutamate forming -glutamylcysteine (-GC)
(hs-CRP, IL-6, and TNF- lab markers that measure inflammation and adipokines, hormones released by fat cells that affect metabolism) 4
Most physicians instruct patients to inject at the same time every day, typically in the morning or at bedtime, depending on the treatment protocol